echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Non-alcoholic fatty liver disease: 10 suggestions for lifestyle adjustments

    Non-alcoholic fatty liver disease: 10 suggestions for lifestyle adjustments

    • Last Update: 2021-12-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world
    .

    The Japanese Society of Gastroenterology (JSGE) and the Japanese Society of Liver Diseases (JSH) formulated relevant guidelines in 2014 and revised the guidelines in 2020
    .

    As stated in the guidelines, weight loss through diet and/or exercise therapy plays a very important role in the treatment of NAFLD patients
    .

    Recently, experts from Japan summarized evidence-based interventions for the treatment of NAFLD patients (especially Asian patients) through life>
    .

    10 clinical practice recommendations on life>
    .

    For obese patients with NAFLD, it is recommended to lose 7% or more of their weight
    .

    Elderly NAFLD patients should pay attention to avoid sarcopenia and weakness during weight loss
    .

    2.
    NAFLD patients should follow a Japanese and/or Mediterranean diet, which is characterized by a rich variety of foods (beans, processed beans, fruits, pickles, mushrooms, and seaweed) and low red meat intake
    .

    Short-term carbohydrate-restricted diets in obese patients with NAFLD can reduce liver fat
    .

    3.
    Patients with lean NAFLD should be encouraged to improve their life>
    .

    For non-obese NAFLD patients, it is recommended to lose 3-5%
    .

    The beneficial exercise regimen for non-obese NAFLD patients is not yet clear
    .

    For elderly patients at high risk of sarcopenia, low-intensity exercises such as walking (20 minutes/day) or resistance exercises of the lower limbs and trunk (2 times/week) are recommended
    .

    4.
    NAFLD patients should limit excessive intake of fructose
    .

    Increasing the intake of dietary fiber can reduce the risk of NAFLD
    .

    5.
    The effects of other dietary nutrients (such as vitamins, trace elements, and phytochemicals) have not been fully studied to support their efficacy in NAFLD patients
    .

    6.
    The total energy intake should be optimized first
    .

    Frequent eating (6 times or more), fast eating, skipping breakfast, and eating snacks at night are related to obesity and NAFLD eating habits and should be adjusted
    .

    7.
    In obesity and NAFLD patients, the plasma levels of branched chain amino acids (BCAA) are usually elevated, and the clinical value of supplementation with BCAA-rich foods or BCAA replacement therapy in these patients is unclear
    .

    When non-alcoholic steatohepatitis (NASH) is in the advanced stage of fibrosis and complications such as hepatic encephalopathy and ascites occur, supplementation of BCAA should be considered to improve liver function reserve
    .

    8.
    It is recommended that NAFLD patients do physical activity/exercise regularly
    .

    The recommended target program is 4.
    5 MET for aerobic exercise, 45 minutes/time, 3 times a week, or resistance exercise 3.
    5 MET, 45 minutes/time, 3 times a week
    .

    Before starting high-intensity physical activity/exercise, the cardiac function of patients at high risk of cardiovascular disease and elderly patients should be assessed
    .

    9.
    Adult patients with NAFLD should limit alcohol (including light drinking) to prevent progression to advanced liver disease
    .

    10.
    Sarcopenia is a common complication of NAFLD
    .

    However, there is no clear conclusion about whether nutritional therapy and exercise intervention should be given priority to NAFLD-related sarcopenia
    .

    Nutritional therapy should be based on BCAA preparations, and exercise intervention should be based on the patient's condition (especially patients with liver cirrhosis)
    .

    References: Kamada Y, Takahashi H, Shimizu M, et al.
    Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review[J].
    J Gastroenterol.
    2021 Dec;56(12): 1045-1061.
    doi: 10.
    1007/s00535-021-01833-9.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.